Other Trustworthy AI in clinical oversight BioPharma DiveAI can accelerate clinical work and preserve traceability, but only if users can trust it.OtherRead full story pharminent March 30, 2026 (Last updated: March 30, 2026) BioPharma Dive AI can accelerate clinical work and preserve traceability, but only if users can trust it. OtherRead full story Post navigation Previous: Otsuka grows in neuroplastogens with $1.225bn Transcend buyNext: Amgen’s BiTE for lung cancer backed for EU approval Related Stories Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026 Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026
